UBP
MRNA icon

Union Bancaire Privee’s Moderna MRNA Stock Holding History

Union Bancaire Privee’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
15,200
+15,000
+7,500% +$776K 0.01% 294
2026
Q1 		$9.03K Hold
200
– – ﹤0.01% 470
2025
Q4 		$5.63K Sell
200
-1,800
-90% -$48.9K ﹤0.01% 472
2025
Q3 		$48.6K Sell
2,000
-4,497
-69% -$125K ﹤0.01% 423
2025
Q2 		$159K Sell
6,497
-15,518
-70% -$409K ﹤0.01% 381
2025
Q1 		$674K Sell
22,015
-15,989
-42% -$567K 0.01% 284
2024
Q4 		$1.45M Buy
+38,004
New +$1.82M 0.03% 243

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Union Bancaire Privee's MRNA Position: Q2 2026 in Review

Union Bancaire Privee increased its Moderna (MRNA) stake by 7,500% in Q2 2026, buying an estimated $776K and bringing the position to 15,200 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #294.

Union Bancaire Privee first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.45M in Q4 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Union Bancaire Privee held 15,200 shares of Moderna worth $1.06M as of Q2 2026.
  • Union Bancaire Privee bought 15,000 Moderna shares in Q2 2026, an estimated $776K.
  • Moderna made up 0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #294 holding.
  • Union Bancaire Privee first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • Union Bancaire Privee's Moderna position peaked at $1.45M in Q4 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.